Hepatocellular carcinoma in pakistan: where do we stand?
- PMID: 23166534
- PMCID: PMC3500772
- DOI: 10.5812/hepatmon.6023
Hepatocellular carcinoma in pakistan: where do we stand?
Abstract
Context: From the 1970s till the mid 1990s, hepatitis B was the most common etiological factor for hepatocellular carcinoma (HCC) in Pakistan. Afterwards, a shift in HCC etiology was observed with a steady rise in hepatitis C virus (HCV) related HCC cases. HCV-3a, which is the most prevalent genotype, is also most frequent in HCV related HCC. There was an increase in the proportion of non-B non-C (NBNC) HCC cases as well, which might be attributed to an increase in non-alcoholic fatty liver disease.
Evidence acquisition: The age-standardized rate for HCC is 7.64/100 000 in males and 2.8/100 000 in females. Male to female ratio is 3.6:1. Usual age of presentation is in the fifth and sixth decade. Most patients present with advanced disease, as they are not in a regular surveillance program. This is more so for patients with NBNC chronic liver disease. As many sonologists in Pakistan are practicing without sufficient training to pick up early lesions, alpha-fetoprotein is still recommended to compliment ultrasound in the surveillance of HCC.
Results: Majority of HCC patients present with nonresectable disease. Interventions such as transarterial chemoembolization, radiofrequency ablation, resection and chemotherapy including sorafenib are available in selected centers. Pakistan appears to be in an area of intermediate endemicity for HCC. There is a need for population based epidemiological studies to estimate the exact disease burden.
Conclusions: Measures to prevent the spread of hepatitis C and B can slow down the epidemic rise in the incidence of HCC in the coming decades. There is a need to implement a proper surveillance program to identify HCC cases at an early stage.
Keywords: Carcinoma, Hepatocellular; Hepatitis C; Pakistan.
Figures




Similar articles
-
Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.Dig Dis Sci. 2020 Jul;65(7):2120-2129. doi: 10.1007/s10620-019-05938-3. Epub 2019 Nov 13. Dig Dis Sci. 2020. PMID: 31722058
-
Clinicopathological characteristics of hepatitis B surface antigen-negative and hepatitis C antibody-negative hepatocellular carcinoma.Oncol Lett. 2015 Oct;10(4):2233-2238. doi: 10.3892/ol.2015.3562. Epub 2015 Aug 4. Oncol Lett. 2015. PMID: 26622825 Free PMC article.
-
Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.World J Gastroenterol. 2009 Oct 28;15(40):5080-5. doi: 10.3748/wjg.15.5080. World J Gastroenterol. 2009. PMID: 19860002 Free PMC article.
-
Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics.Clin Med Insights Oncol. 2014 May 19;8:71-6. doi: 10.4137/CMO.S9926. eCollection 2014. Clin Med Insights Oncol. 2014. PMID: 24899827 Free PMC article. Review.
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
Cited by
-
Changes in the Epidemiology of Hepatocellular Carcinoma in Asia.Cancers (Basel). 2022 Sep 15;14(18):4473. doi: 10.3390/cancers14184473. Cancers (Basel). 2022. PMID: 36139633 Free PMC article. Review.
-
Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective.Gastroenterol Res Pract. 2016;2016:5942306. doi: 10.1155/2016/5942306. Epub 2016 Feb 3. Gastroenterol Res Pract. 2016. PMID: 26955390 Free PMC article. Review.
-
Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population.Hepat Mon. 2013 May 8;13(5):e7612. doi: 10.5812/hepatmon.7612. Print 2013 May. Hepat Mon. 2013. PMID: 23922558 Free PMC article.
-
The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial.Hepat Mon. 2013 May 21;13(5):e9270. doi: 10.5812/hepatmon.9270. Print 2013 May. Hepat Mon. 2013. PMID: 23930133 Free PMC article.
-
Detection of Primary Hepatocellular Carcinoma on 18F-Fluorodeoxyglucose Positron Emission Tomography-computed Tomography.Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):66-72. doi: 10.5005/jp-journals-10018-1409. Euroasian J Hepatogastroenterol. 2023. PMID: 38222944 Free PMC article.
References
-
- Donato F, Boffetta P, MA P. Metaanalysis of epidemiological studies on the combined effect of Hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer. 1998;75:347–54. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials